Aminoglycosides
| Drug | Dosage | Remarks |
|---|---|---|
| Amikacin | Adults, children and older infants: 15 mg/kg/day IM/IV as single dose or divided 8-12 hourly |
Adverse Reactions
|
Antiasthmatic & COPD Preparations
| Drug | Dosage | Remarks |
|---|---|---|
| Salbutamol | Children 2-6 years old: 1-2 mg PO 6-8 hourly Children 6-12 years old: 2 mg PO 6-8 hourly Children >12 years old: 2-4 mg PO 6-8 hourly Adults: 2-4 mg PO 6-8 hourly May be increased up to 8 mg |
Adverse Reactions
|
| Terbutaline | Children 12-15 years old: 2.5 mg PO 8 hourly Adults and children >15 years old: 2.5-5 mg PO 8 hourly |
Adverse Reactions
|
Antibacterial Combination
| Drug | Dosage1 | Remarks |
|---|---|---|
|
Co-trimoxazole (Sulfamethoxazole [SMZ] and Trimethoprim [TM]) |
Children 6 months-5 years old: 200 mg SMZ/40 mg TM PO 12 hourly Children 6-12 years old: 400 mg SMZ/80 mg TM PO 12 hourly Adults and children >12 years old: 800 mg SMZ/160 mg TM PO 12 hourly |
Adverse Reactions
|
| 1Duration of treatment: 7-10 days minimum. More serious acute exacerbations may require hospitalization and administration of IV antibiotics. | ||
Cephalosporins
| Drug | Dosage1 | Remarks |
|---|---|---|
| First Generation | ||
| Cefadroxil | 500-1,000 mg PO 12 hourly |
Adverse Reactions
|
| Cefalexin |
250 mg PO 6 hourly or 500 mg PO 8 hourly Max dose: 4 g/day |
|
| Second Generation | ||
| Cefaclor |
Children >1 month: 20-40 mg/kg/day PO divided 8-12 hourly Max dose: 1 g/day Adults: 250-500 mg PO 8 hourly Max dose: 4 g/day |
Adverse Reactions
|
| Cefminox |
Children: 20 mg/kg IV injection/infusion 6-8 hourly Adults: 2 g/day IV injection/infusion divided 12 hourly May increase up to 6 g/day IV injection/infusion divided 6-8 hourly |
|
| Cefotiam |
Adults: 200-400 mg PO 8-12 hourly or 0.5-2 g/day IV/IM divided 6-12 hourly |
|
| Cefuroxime |
Infants and children <40 kg: 30-100 mg/kg/day divided 6-8 hourly Adults and children ≥40 kg: 250-500 mg PO 12 hourly or 750 mg-1,500 mg IM/IV 6-8 hourly |
|
| Third Generation | ||
| Cefditoren pivoxil | 100-300 mg PO 8 hourly | |
| Cefixime |
Children 6 months-10 years old and <50 kg: 8 mg/kg/day PO divided 12-24 hourly Adults and children ≥50 kg: 200-400 mg/day PO divided 12-24 hourly |
|
| Cefpodoxime | Adults and children ≥12 years old: 200 mg PO 12 hourly |
|
| Ceftazidime |
Children >1 month-12 years old: 30-50 mg/kg IM/IV 12 hourly Adults and children ≥40 kg: 1-2 g IV 8-12 hourly |
|
| Ceftizoxime |
Children ≥6 months: 40-80 mg/kg/day IV divided 6-12 hourly May increase up to 120 mg/kg/day for severe or intractable infections Adults: 500 mg IM/IV/day divided 6-12 hourly May increase up to 4 g for severe or intractable infections |
|
| 1Duration of treatment: 7-10 days minimum. More serious acute exacerbations may require hospitalization and administration of IV antibiotics. | ||
Cough & Cold Preparations
| Drug | Dosage | Remarks |
|---|---|---|
| Acetylcysteine |
Children 2-5 years old: 100 mg PO 8-12 hourly Children 6-14 years old: 200 mg PO 12 hourly Adults and children ≥14 years old: 200 mg PO 8-12 hourly or 300 mg PO 12 hourly or 600 mg PO 24 hourly |
Adverse Reactions
|
| Ambroxol |
Children <2 years old: 7.5 mg PO 12 hourly Children 2-5 years old: 7.5 mg PO 8-12 hourly Children 6-10 years old: 7.5-15 mg PO 8-12 hourly Adults and children >10 years old: 30 mg PO 8-12 hourly Extended release: 75 mg PO 24 hourly |
|
| Bromhexine |
Children <2 years old: 1 mg PO 8 hourly Children 2-5 years old: 2 mg PO 8 hourly or 4 mg PO 12 hourly Children 6-12 years old: 4-8 mg PO 8 hourly Adults and children >12 years old: 8-16 mg PO 8 hourly |
|
| Carbocisteine (Carbocysteine) |
Children 1-2 years old: 60 mg PO 6 hourly Children 2-5 years old: 100 mg PO 8 hourly Children 6-12 years old: 200 mg PO 8 hourly Adults and children >12 years old: 750 mg PO 8 hourly or 500 mg PO 8 hourly or 375 mg PO 6 hourly |
|
| Cyclidrol (Sobrerol) |
Children >2 years old: 80 mg PO 12 hourly Adults: 200 mg PO 12 hourly |
Adverse Reactions
|
| Erdosteine |
Children 15-19 kg: 175 mg PO 12 hourly Children 20-30 kg: 175 mg PO 8-12 hourly Children >30 kg: 175 mg PO 8 hourly or 350 mg PO 12 hourly Adults: 300 mg PO 8-12 hourly or 350 mg PO 12 hourly |
Adverse Reactions
|
| Guaifenesin |
Children 1-6 years old: 25-50 mg PO 6-8 hourly or 50-100 mg PO 4 hourly Children 7-12 years old: 50-100 mg PO 6-8 hourly or 100-200 mg PO 4 hourly Adults and children ≥12 years old: 100-200 mg PO 6-8 hourly or 200-400 mg PO 4 hourly |
Adverse Reactions
|
Dipeptidyl Peptidase 1 (DPP1) Inhibitor
| Drug | Dosage | Remarks |
|---|---|---|
| Brensocatinib | Adults and children >12 years old: 10 mg PO 24 hourly or 25 mg PO 24 hourly |
Adverse Reactions
|
Macrolides
| Drug | Dosage | Remarks |
|---|---|---|
| Clarithromycin | Children 8-11 kg: 125 mg PO 12 hourly Children 12-19 kg: 250 mg PO 12 hourly Children 20-29 kg: 375 mg PO 12 hourly Children 30-40 kg: 500 mg PO 12 hourly Infants, children and adolescents: 7.5 mg/kg/dose PO 12 hourly Adults and children >12 years old: 250-500 mg PO 12 hourly |
Adverse Reactions
|
| Erythromycin | Children: 30-50 mg/kg/day PO divided 8-12 hourly Adults: 250-500 mg PO 6 hourly or 400-500 mg PO 12 hourly or 800 mg PO 12 hourly Max dose: 4 g/day |
Adverse Reactions
|
| Midecamycin | Adults: 900-1,800 mg/day PO divided 8-12 hourly |
Adverse Reactions
|
Other Antibiotics
| Drug | Dosage | Remarks |
|---|---|---|
| Colistin (Colistimethate Na) |
75-150 mg inhaled via nebulizer 12 hourly |
Adverse Reactions
|
Other Beta-lactams
| Drug | Dosage | Remarks |
|---|---|---|
| Meropenem | Children >3 months-12 years old and <50 kg: 10-20 mg/kg IV 8 hourly Adults and children >50 kg: 0.5-1 g IV 8 hourly |
Adverse Reactions
|
Penicillins
| Drug | Dosage1 | Remarks |
|---|---|---|
| Aminopenicillins with or without Beta-lactamase Inhibitors | ||
| Amoxicillin |
Children ≤3 months: 20-30 mg/kg/day PO divided 12 hourly Children >3 months and <40 kg: 20-50 mg/kg/day PO divided 8-12 hourly Adults and children ≥40 kg: 250-500 mg PO 8 hourly or 500 mg PO 12 hourly |
Adverse Reactions
|
|
Amoxicillin/clavulanic acid (Co-amoxiclav, Amoxicillin/clavulanate) |
Children <40 kg: 20 mg/5 mg/kg/day to 60 mg/15 mg/kg/day PO divided 8 hourly Adult and children ≥40 kg: 375-625 mg PO 8 hourly or 625-1,000 mg PO 12 hourly |
|
| Antipseudomonal Penicillins with or without Beta-lactamase Inhibitors | ||
|
Piperacillin/tazobactam |
Children 2-9 months old: 80 mg/kg IV 8 hourly based on Piperacillin Childn ≥9 months old or up to 40 kg: 100 mg/kg IV 8 hourly based on Piperacillin Adults: 3.375 g IV infusion 6 hourly or 4.5 g IV infusion 8 hourly Max dose: 12 g Piperacillin/1.5 g tazobactam |
|
|
Ticarcillin/clavulanic acid (Ticarcillin/clavulanate) |
Children <60 kg: 200-300 mg/kg/day IV divided 4-6 hourly based on Ticarcillin Adults and children ≥60 kg: 3.1 g/day IV 4-6 hourly |
|
| Antistaphylococcal Penicillin | ||
| Cloxacillin |
Children ≤2 years old: 125 mg PO 6-8 hourly Children 3-10 years old: 250 mg PO 6-8 hourly Adults: 250-500 mg PO 6 hourly |
|
| 1Duration of treatment: 7-10 days minimum. More serious acute exacerbations may require hospitalization and administration of IV antibiotics. | ||
Quinolones
| Drug | Dosage1 | Remarks |
|---|---|---|
| Ciprofloxacin | 250-750 mg PO 12 hourly or 200-400 mg IV 8-12 hourly |
Adverse Reactions
|
| Levofloxacin | 250-500 mg PO 12-24 hourly or 750 mg PO 24 hourly |
|
| Ofloxacin | 100-200 mg PO 8-12 hourly | |
| 1Duration of treatment: 7-10 days minimum. More serious acute exacerbations may require hospitalization and administration of IV antibiotics. | ||
Tetracyclines
| Drug | Dosage | Remarks |
|---|---|---|
| Doxycycline | 200 mg PO as a single dose or divided 12 hourly initially then 100 mg/day PO 24 hourly |
Adverse Reactions
|
Disclaimer
All dosage recommendations are for non-pregnant and non-breastfeeding women, and non-elderly adults with normal renal and hepatic function unless otherwise stated.
Not all products are available or approved for above use in all countries.
Products listed in the Drug Summary are based on indications stated in the locally approved product monographs.
Please refer to local product monographs in Related MIMS Drugs for country-specific prescribing information.
Not all products are available or approved for above use in all countries.
Products listed in the Drug Summary are based on indications stated in the locally approved product monographs.
Please refer to local product monographs in Related MIMS Drugs for country-specific prescribing information.
